[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.22. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Whitmore  SMLeake  NB Complementary therapies: an adjunct to traditional therapies.  Nurse Pract. 1996;2110- 13Google Scholar
2.
Vickers  A Yes, but how do we know it's true? knowledge claims in massage and aromatherapy.  Complement Ther Nurs Midwifery. 1997;363- 65Google ScholarCrossref
3.
Martin  GN Olfactory remediation: current evidence and possible applications.  Soc Sci Med. 1996;4363- 70Google ScholarCrossref
4.
Walsh  D Using aromatherapy in the management of psoriasis.  Nurs Stand. 1996;1153- 56Google Scholar
5.
Brooker  DJSnape  MJohnson  EWard  DPayne  M Single case evaluation of the effects of aromatherapy and massage on disturbed behaviour in severe dementia.  Br J Clin Psychol. 1997;36287- 296Google ScholarCrossref
6.
Welsh  C Touch with oils: a pertinent part of holistic hospice care.  Am J Hosp Palliat Care. 1997;1442- 44Google ScholarCrossref
7.
Dwivedi  CAbu-Ghazaleh  A Chemopreventive effects of sandalwood oil on skin papillomas in mice.  Eur J Cancer Prev. 1997;6399- 401Google ScholarCrossref
8.
Hammer  KACarson  CFRiley  TV Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil).  Am J Infect Control. 1996;24186- 189Google ScholarCrossref
9.
Nenoff  PHaustein  UFBrandt  W Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro.  Skin Pharmacol. 1996;9388- 394Google ScholarCrossref
10.
Yamane  MAWilliams  ACBarry  BW Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action.  J Pharm Pharmacol. 1995;47978- 989Google ScholarCrossref
11.
Weiss  RRJames  WD Allergic contact dermatitis from aromatherapy.  Am J Contact Dermat. 1997;8250- 251Google Scholar
12.
Koo  YMWilliam  VRShellow  MDHallman  CPEdwards  JE Alopecia areata and increased prevalence of psychiatric disorders.  Int J Dermatol. 1994;33849- 850Google ScholarCrossref
13.
van der Steen  PHMvan Baar  HMJHapple  RBoezeman  JMBPerret  MJ Prognostic factors in the treatment of alopecia areata with diphencyprone.  Am Acad Dermatol. 1991;24227- 230Google ScholarCrossref
14.
Gordon  PMAldridge  RDMcVittie  EHunter  JAA Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow up.  Br J Dermatol. 1996;134869- 871Google ScholarCrossref
15.
De Prost  YPaquez  FTouraine  R Dinitrochlorobenzene treatment of alopecia areata.  Arch Dermatol. 1982;118542- 545Google ScholarCrossref
16.
Weise  KKretzschmar  LJohn  SMHamm  H Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance.  Dermatology. 1996;192129- 133Google ScholarCrossref
17.
MacDonald Hull  SNorris  JF Diphencyprone in the treatment of long standing alopecia areata.  Br J Dermatol. 1988;119367- 374Google ScholarCrossref
18.
Pocock  SJHughes  MD Estimation issues in clinical trials and overviews.  Stat Med. 1990;9657- 671Google ScholarCrossref
19.
Frattasio  AGermino  MCargnello  SPatrone  P Side-effects during treatment with SADBE.  Contact Dermatitis. 1997;36118- 119Google ScholarCrossref
20.
Shapiro  JTan  JHo  VTron  V Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.  J Invest Dermatol. 1995;104(suppl 5)36SGoogle ScholarCrossref
21.
Taylor  CRHawk  JLM PUVA treatment of alopecia areata parrialis, totalis and universalis: audit of ten years' experience at St. John's Institute of Dermatology.  Br J Dermatol. 1995;133914- 918Google ScholarCrossref
Study
November 1998

Randomized Trial of Aromatherapy: Successful Treatment for Alopecia Areata

Author Affiliations

From the Department of Dermatology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland.

Arch Dermatol. 1998;134(11):1349-1352. doi:10.1001/archderm.134.11.1349
Abstract

Objective  To investigate the efficacy of aromatherapy in the treatment of patients with alopecia areata.

Design  A randomized, double-blind, controlled trial of 7 months' duration, with follow-up at 3 and 7 months.

Setting  Dermatology outpatient department.

Participants  Eighty-six patients diagnosed as having alopecia areata.

Intervention  Eighty-six patients were randomized into 2 groups. The active group massaged essential oils (thyme, rosemary, lavender, and cedarwood) in a mixture of carrier oils (jojoba and grapeseed) into their scalp daily. The control group used only carrier oils for their massage, also daily.

Main Outcome Measures  Treatment success was evaluated on sequential photographs by 2 dermatologists (I.C.H. and A.D.O.) independently. Similarly, the degree of improvement was measured by 2 methods: a 6-point scale and computerized analysis of traced areas of alopecia.

Results  Nineteen (44%) of 43 patients in the active group showed improvement compared with 6 (15%) of 41 patients in the control group (P=.008). An alopecia scale was applied by blinded observers on sequential photographs and was shown to be reproducible with good interobserver agreement (κ=0.84). The degree of improvement on photographic assessment was significant (P=.05). Demographic analysis showed that the 2 groups were well matched for prognostic factors.

Conclusions  The results show aromatherapy to be a safe and effective treatment for alopecia areata. Treatment with these essential oils was significantly more effective than treatment with the carrier oil alone (P=.008 for the primary outcome measure). We also successfully applied an evidence-based method to an alternative therapy.

×